147 related articles for article (PubMed ID: 28728450)
1. Chronic lymphocytic leukemia in a patient with well-controlled HIV infection: successful treatment with ibrutinib.
England JT; Leitch HA
Leuk Lymphoma; 2018 Mar; 59(3):752-754. PubMed ID: 28728450
[No Abstract] [Full Text] [Related]
2. Feasibility and safety of therapy with ibrutinib after antiviral control of hepatitis B virus (HBV) reactivation in chronic lymphocytic leukemia patients.
Molica S; Levato L; Mirabelli R; Tedeschi A; Lentini M
Leuk Lymphoma; 2018 Nov; 59(11):2734-2736. PubMed ID: 29465275
[No Abstract] [Full Text] [Related]
3. Successful treatment with ribavirine for chronic hepatitis E in chronic lymphocytic leukemia treated with Ibrutinib.
Boudin L; Patient M; Tsitsi Nding Tsogou P; Roméo E; Bladé JS; de Jauréguiberry JP
Bull Cancer; 2019 Jan; 106(1):84-85. PubMed ID: 30579570
[No Abstract] [Full Text] [Related]
4. HBV reactivation in CLL patients with occult HBV infection treated with ibrutinib without viral prophylaxis.
Innocenti I; Morelli F; Autore F; Corbingi A; Pasquale R; Sorà F; Pompili M; Laurenti L
Leuk Lymphoma; 2019 May; 60(5):1340-1342. PubMed ID: 30730231
[No Abstract] [Full Text] [Related]
5. Is HBV prophylaxis required during CLL treatment with ibrutinib?
Tedeschi A; Frustaci AM; Mazzucchelli M; Cairoli R; Montillo M
Leuk Lymphoma; 2017 Dec; 58(12):2966-2968. PubMed ID: 28535112
[No Abstract] [Full Text] [Related]
6. Successful use of Bruton's kinase inhibitor, ibrutinib, to control paraneoplastic pemphigus in a patient with paraneoplastic autoimmune multiorgan syndrome and chronic lymphocytic leukaemia.
Lee A; Sandhu S; Imlay-Gillespie L; Mulligan S; Shumack S
Australas J Dermatol; 2017 Nov; 58(4):e240-e242. PubMed ID: 28295171
[TBL] [Abstract][Full Text] [Related]
7. Spuriously low lymphocyte count associated with pseudoerythroblastemia in a patient with chronic lymphocytic leukemia treated with ibrutinib.
Robier C; Beham-Schmid C; Neubauer M
Clin Chem Lab Med; 2018 Apr; 56(5):e112-e114. PubMed ID: 29252190
[No Abstract] [Full Text] [Related]
8. Bilateral cystoid macular edema in a patient with chronic lymphocytic leukemia treated with ibrutinib.
Saenz-de-Viteri M; Cudrnak T
Leuk Lymphoma; 2019 Mar; 60(3):842-844. PubMed ID: 30188238
[No Abstract] [Full Text] [Related]
9. Ibrutinib for Chronic Lymphocytic Leukemia.
Ruchlemer R; Ben Ami R; Lachish T
N Engl J Med; 2016 Apr; 374(16):1593-4. PubMed ID: 27096597
[No Abstract] [Full Text] [Related]
10. Ibrutinib for Chronic Lymphocytic Leukemia.
Rigolin GM; Cavazzini F; Cuneo A
N Engl J Med; 2016 Apr; 374(16):1593. PubMed ID: 27096596
[No Abstract] [Full Text] [Related]
11. Ibrutinib for Chronic Lymphocytic Leukemia.
Sharman JP; Mato AR; Keating MJ
N Engl J Med; 2016 Apr; 374(16):1592-3. PubMed ID: 27096595
[No Abstract] [Full Text] [Related]
12. Ibrutinib for Chronic Lymphocytic Leukemia.
Burger JA; Styles L; Kipps TJ
N Engl J Med; 2016 Apr; 374(16):1594-5. PubMed ID: 27096594
[No Abstract] [Full Text] [Related]
13. [Chronic Lymphocytic Leukemia. New targeted therapy option Ibrutinib].
Bruhn C
Med Monatsschr Pharm; 2014 Jul; 37(7):268-9. PubMed ID: 25065170
[No Abstract] [Full Text] [Related]
14. Resolution of eosinophilia and elevated immunoglobulin E with ibrutinib for chronic lymphocytic leukemia.
Harada K; Brooks JP; Lobo FM
Ann Allergy Asthma Immunol; 2018 Nov; 121(5):629-630.e1. PubMed ID: 30009879
[No Abstract] [Full Text] [Related]
15. Management of hypogammaglobulinemia and recurrent infections in a chronic lymphocytic leukemia patient receiving ibrutinib.
Jiang F; Verma P
Ann Allergy Asthma Immunol; 2018 Mar; 120(3):324-325. PubMed ID: 29174859
[No Abstract] [Full Text] [Related]
16. Ibrutinib in relapsed chronic lymphocytic leukemia.
Neffendorf JE; Gout I; Hildebrand GD
N Engl J Med; 2013 Sep; 369(13):1277. PubMed ID: 24066759
[No Abstract] [Full Text] [Related]
17. Ibrutinib in relapsed chronic lymphocytic leukemia.
Byrd JC; O'Brien S; James DF
N Engl J Med; 2013 Sep; 369(13):1278-9. PubMed ID: 24066758
[No Abstract] [Full Text] [Related]
18. The effectiveness of ibrutinib in chronic lymphocytic leukaemia: a nationwide, population-based study in the Netherlands.
van der Straten L; Levin MD; Visser O; Blijlevens NMA; Cornelissen JJ; Doorduijn JK; Kater AP; Dinmohamed AG
Br J Haematol; 2020 Mar; 188(6):e109-e112. PubMed ID: 31991479
[No Abstract] [Full Text] [Related]
19. Ibrutinib for chronic lymphocytic leukemia: international experience from a named patient program.
Hillmen P; Diels J; Healy N; Iraqi W; Aschan J; Wildgust M
Haematologica; 2018 May; 103(5):e204-e206. PubMed ID: 29419428
[No Abstract] [Full Text] [Related]
20. Successful Treatment of Chronic Lymphocytic Leukemia Multifocal Central Nervous System Involvement with Ibrutinib.
Christoforidou A; Kapsas G; Bezirgiannidou Z; Papamichos S; Kotsianidis Ι
Turk J Haematol; 2018 May; 35(2):147-149. PubMed ID: 29391330
[No Abstract] [Full Text] [Related]
[Next] [New Search]
